Mirae Asset Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹7404 Cr | ₹2313 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 01 Jun 2004 | 10 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 15% |
| Expense Ratio | 1.82 | 1.97 |
| Manager | Sailesh Raj Bhan | Vrijesh Kasera |
| ISIN Code | INF204K01968 | INF769K01EA2 |
| Exits Load | Exit load of 1% if redeemed within 1 month./365 | I. For investors who have opted for SWP under the plan: a) 15% of the units allotted (including Switch-in/STP - in) on or before completion of 365 days from the date of allotment of units: Nil. b) Any redemption in excess of such limits in the first 365 d/365 |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | -4.24% | -5.86% |
| 6 Month | 15.32% | 18.28% |
| 1 Year | 35.43% | 37.35% |
| 3 Year | 18.33% | 16.84% |
| 5 Year | 26.98% | 27.76% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 31.44% | 36.68% |
| 3 Year | 30.78% | 30.25% |
| 5 Year | 25.57% | 25.59% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 17.79% | 23.48% |
| 3 Year | 20.87% | 20.47% |
| 5 Year | 20.18% | 23.92% |
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 14.36% | 14.65% |
| Sharp | 0.68% | 0.62% |
| Beta | 0.91% | 0.95% |
| Alpha | 1.57% | 0.72% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Vrijesh Kasera |
| Total AUM | ₹96086 Cr | ₹12061 Cr |
| Fund Manage | 5 | 4 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.45 |
| Large Cap | 45.96 | 46.58 |
| Mid Cap | 27.12 | 40.25 |
| Small Cap | 22.52 | 12.72 |
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.4 | 0.44 |
| Pharmaceuticals & Biotechnology | 75.86 | - |
| Healthcare Services | 17.38 | - |
| Retailing | 2.36 | - |
| Healthcare | - | 97.47 |
| Chemicals | - | 0.82 |
| Financial | - | 1.26 |
| Unclassified | - | 0.01 |
Top Comparisons
Mirae Asset Corporate Bond Fund Regular Growth
3Y Returns5.42%
UTI Corporate Bond Fund - Regular Plan - Growth Option
3Y Returns5.86%
Kotak NASDAQ 100 Fund of Fund - Regular Plan - Growth
3Y Returns12.6%
Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
3Y Returns11.03%
Mahindra Manulife Equity Savings Fund - Regular Plan - Growth
3Y Returns7.46%
UTI Conservative Hybrid Fund - Regular Plan - Growth Option
3Y Returns9.61%
ICICI Prudential Gilt Fund - Growth
3Y Returns6.11%
Kotak Gilt-Investment Regular-Growth
3Y Returns5.51%